GPX2 can promote the migration and invasion of prostate, pancreatic, and ovarian cancer cells through the Wnt/β-catenin/EMT pathway (Li, Dai & Niu, 2020; Wang et al., 2019; Zhang et al., 2018). Here, GPX2 is linked to ovarian cancer.